NCT05932459View on ClinicalTrials.gov

A Study to Evaluate the Bioavailability, Food Effect and Pharmacokinetics of Deuremidevir Hydrobromide for Suspension

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

July 9, 2023

Primary Completion Date

September 4, 2023

Study Completion Date

September 4, 2023

Conditions
Healthy Subjects
Interventions
DRUG

Deuremidevir Hydrobromide for Suspension 100mg

Take it with 240ml water in fasted condition.

DRUG

Deuremidevir Hydrobromide for Suspension 300mg

Take it with water in fasted condition or after taking infant formula.

DRUG

Deuremidevir Hydrobromide for Suspension 25mg

Take it with 240ml water on an empty stomach.

DRUG

Deuremidevir Hydrobromide tablets 100mg

Take it with 240ml water in fasted condition.

Trial Locations (1)

201900

Huashan Hospital affiliated to Fudan University, Shanghai

All Listed Sponsors
lead

Vigonvita Life Sciences

INDUSTRY